
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
George Clinical, a full-service CRO in the Asia-Pacific region, has acquired Memphis-based Vector Oncology's Pharma Services Division.
George Clinical, a full-service CRO in the Asia-Pacific region, has acquired Memphis-based Vector Oncology's Pharma Services Division. This acquisition aims to assist George Clinical in providing oncology trial delivery solutions throughout the Asia-Pacific region.
Read the full release






